Literature DB >> 24742666

The lateralized smell test for detecting Alzheimer's disease: failure to replicate.

Richard L Doty1, Edgardo A Bayona2, Daniel S Leon-Ariza3, Juan Cuadros4, Inna Chung5, Britney Vazquez5, Fidias E Leon-Sarmiento6.   

Abstract

OBJECTIVES: A widely publicized study by Stamps, Bartoshuk and Heilman (2013) reported that a simple measure of left:right naris differences in the ability to detect the odor of peanut butter is a sensitive marker of Alzheimer's disease (AD). AD patients were said to have abnormal smell function on the left side of the nose and normal function on right side of the nose. In light of its implications for medical practice and the world-wide publicity that it engendered, we sought to replicate and expand this work.
METHODS: Two studies were performed. In the first, 15 AD patients were tested according to the procedures described by Stamps et al. in which the nostril contralateral to the tested side was occluded by the patient using lateral pressure from the index finger. Since this can potentially distort the contralateral naris, we repeated the testing using tape for naris occlusion. In the second, 20 AD patients were administered 20 odors of the University of Pennsylvania Smell Identification Test (UPSIT) to each side of the nose, with the contralateral naris being closed with tape. In both studies, the order of the side of testing was systematically counterbalanced.
RESULTS: No evidence of a left:right asymmetry on any test measure was observed.
CONCLUSION: Although hyposmia is well-established in AD, no meaningful asymmetry in smell perception is apparent. If olfactory function on the right side of the nose was normal as claimed, then AD patients should exhibit normal function when tested bilaterally, a phenomenon not seen in dozens of AD-related olfactory studies.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; Laterality; Neurodegeneration; Olfaction; Psychophysics; UPSIT

Mesh:

Year:  2014        PMID: 24742666      PMCID: PMC4167392          DOI: 10.1016/j.jns.2014.03.022

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  28 in total

1.  Unirhinal norms for the University of Pennsylvania Smell Identification Test.

Authors:  Kimberley P Good; Jeffrey S Martzke; Marie Abi Daoud; Lili C Kopala
Journal:  Clin Neuropsychol       Date:  2003-05       Impact factor: 3.535

2.  Asymmetry of neurodegenerative disease-related pathologies: a cautionary note.

Authors:  Harald Stefanits; Herbert Budka; Gabor G Kovacs
Journal:  Acta Neuropathol       Date:  2012-01-06       Impact factor: 17.088

3.  Bilateral detection thresholds in dextrals and sinistrals reflect the more sensitive side of the nose, which is not lateralized.

Authors:  S A Betchen; R L Doty
Journal:  Chem Senses       Date:  1998-08       Impact factor: 3.160

4.  Tests of human olfactory function: principal components analysis suggests that most measure a common source of variance.

Authors:  R L Doty; R Smith; D A McKeown; J Raj
Journal:  Percept Psychophys       Date:  1994-12

5.  A study of the test-retest reliability of ten olfactory tests.

Authors:  R L Doty; D A McKeown; W W Lee; P Shaman
Journal:  Chem Senses       Date:  1995-12       Impact factor: 3.160

6.  Asymmetry of SPECT perfusion image patterns as a diagnostic feature for Alzheimer's disease.

Authors:  Vassili A Kovalev; Lennart Thurfjell; Roger Lundqvist; Marco Pagani
Journal:  Med Image Comput Comput Assist Interv       Date:  2006

7.  Olfactory testing differentiates between progressive supranuclear palsy and idiopathic Parkinson's disease.

Authors:  R L Doty; L I Golbe; D A McKeown; M B Stern; C M Lehrach; D Crawford
Journal:  Neurology       Date:  1993-05       Impact factor: 9.910

8.  Alzheimer's disease: anterior-posterior and lateral hemispheric alterations in cortical glucose utilization.

Authors:  R P Friedland; T F Budinger; E Koss; B A Ober
Journal:  Neurosci Lett       Date:  1985-02-04       Impact factor: 3.046

9.  Presence of both odor identification and detection deficits in Alzheimer's disease.

Authors:  R L Doty; P F Reyes; T Gregor
Journal:  Brain Res Bull       Date:  1987-05       Impact factor: 4.077

10.  Olfactory dysfunction in parkinsonism: a general deficit unrelated to neurologic signs, disease stage, or disease duration.

Authors:  R L Doty; D A Deems; S Stellar
Journal:  Neurology       Date:  1988-08       Impact factor: 9.910

View more
  3 in total

1.  Olfactory dysfunction in the 3xTg-AD model of Alzheimer's disease.

Authors:  Darlene A Mitrano; Sam E Houle; Patrick Pearce; Ricardo M Quintanilla; Blakely K Lockhart; Benjamin C Genovese; Rachel A Schendzielos; Emma E Croushore; Ethan M Dymond; James W Bogenpohl; Harold J Grau; Lisa Smith Webb
Journal:  IBRO Neurosci Rep       Date:  2021-01-08

2.  Smell deficits in COVID-19 and possible links with Parkinson's disease.

Authors:  Aron Emmi; Michele Sandre; Andrea Porzionato; Angelo Antonini
Journal:  Int Rev Neurobiol       Date:  2022-09-06       Impact factor: 4.280

Review 3.  Olfactory dysfunction in Alzheimer's disease.

Authors:  Yong-Ming Zou; Da Lu; Li-Ping Liu; Hui-Hong Zhang; Yu-Ying Zhou
Journal:  Neuropsychiatr Dis Treat       Date:  2016-04-15       Impact factor: 2.570

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.